Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

REPROS THERAPEUTICS INC. (RPRX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues and other income          
Interest income  0.00.00.00.00.00.0 0.0
    Total revenues and other income  0.00.00.00.00.00.00.40.6
            Total revenues and other income growth  327.3%22.2%0.0%200.0%50.0%-99.5%-23.6%27.3%
Expenses          
Research and development  12.824.127.123.714.18.72.923.1
General and administrative  4.65.15.44.84.83.82.34.7
    Total expenses  17.329.232.528.518.912.55.227.8
    Net loss  -17.3-29.2-32.5-28.5-18.9-12.5-4.8-27.2
   
Basic and diluted loss per share  ($0.70)($1.20)($1.39)($1.37)($1.23)($1.04)($0.59)($6.28)
   
Shares used in loss per share calculation:          
   
Diluted  24.724.323.420.815.312.08.14.3

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy